NCT06759701View on ClinicalTrials.gov

Pre-Surgical Tirzepatide-Assisted Weight Loss in Overweight and Obese Men With Intermediate Risk Prostate Cancer: A Pilot Feasibility Study

EARLY_PHASE1RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 2, 2025

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2028

Conditions
DiabetesProstate Cancer
Interventions
DRUG

Tirzepatide

Participants will perform weekly self-injection of tirzepatide as standard of care, following manufacturer instructions

Trial Locations (1)

77030

RECRUITING

The University of Texas M. D. Anderson Cancer Center, Houston

All Listed Sponsors
lead

M.D. Anderson Cancer Center

OTHER